METHOD FOR DIAGNOSING COGNITIVE IMPAIRMENT IN PATIENTS WITH HIV-ASSOCIATED ENCEPHALOPATHY IN THE AIDS STAGE Russian patent published in 2022 - IPC G01N33/573 G01N33/543 A61B17/34 

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to neurology and clinical laboratory diagnostics, and can be used to diagnose cognitive impairment in patients with HIV-associated encephalopathy in the AIDS stage. In the cerebrospinal fluid of patients, the concentration of neuron-specific enolase (NSE) is determined. At its concentration above 21.5 ng/ml, the presence of cognitive impairment is diagnosed in patients with HIV-associated encephalopathy in the AIDS stage.

EFFECT: method provides accessibility and objectification of diagnostics of cognitive disorders in patients with HIV-associated encephalopathy in the AIDS stage by increasing the accuracy of diagnostics of cognitive dysfunction based on the results of a laboratory study of cerebrospinal fluid, which determines the intensity of damage to neurocytes.

1 cl, 4 ex